Global Spinal Muscular Atrophy Market

google

The Global Spinal Muscular Atrophy Market accounted for US$ 2.5 billion in 2020 and is estimated to be US$ 16.9 billion by 2030 and is anticipated to register a CAGR of 21.35%. Mutations in the survival motor neuron 1 gene, SMN1, cause spinal muscular atrophy, an autosomal recessive condition characterised by degeneration of motor neurons in the spinal cord. SMA is a rare hereditary disorder that affects the component of the neurological system that controls voluntary muscle movement. SMA is caused by the loss of motor neurons in the spinal cord, which causes muscles to weaken and movement issues. There are four forms of spinal muscular atrophy, each of which begins at a different age.

The report " Global Spinal Muscular Atrophy Market, By Disease Type (Type I, Type II, Type III, and Type IV), By Age (Infant and Adult), By Treatment (Drug Therapy and Gene Therapy) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029’’

Key Highlights:

In July 2021, Roche has launched a spinal muscular atrophy (SMA) treatment drug in India priced at around 6lakhper bottle. The drug Evrysdi is approved for the treatment of SMA in adults and children 2 months of age and older, Roche said it was approved by the Indian health authorities after reviewing its efficacy and safety data from 3 global clinical studies designed to represent a broad spectrum of people living with SMA.
In July 2021, SadBaby has pledged to help SMA (Spinal Muscular Atrophy) patients in improving their life and ensuring that no child is left uncured. The project launched by SadBaby focuses on gathering funds through their supporters and investors and utilizes it for meeting the financial requirements of the SMA patients..

Analyst View:

Rising cases of spinal muscular atrophy globally, as well as an increase in the number of ongoing clinical trial studies and increased research and development funding from the government and various healthcare regulatory bodies, are expected to propel the global spinal muscular atrophy market forward over the forecast period. Another factor driving the market is the initiatives performed by various public and nonprofit organizations to raise awareness about SMA. Treatment therapy for this illness is also being developed by research institutes which is also increasing the markets growth.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on ‘Global Spinal Muscular Atrophy Market, By Disease Type (Type I, Type II, Type III, and Type IV), By Age (Infant and Adult), By Treatment (Drug Therapy and Gene Therapy) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029’

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Spinal-Muscular-Atrophy-Market-82

To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]m

google

The Global Spinal Muscular Atrophy Market Growth Accelerated By Rising Adoption Of Gene Therapy

ashwini bakhade 2024-02-01

The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 2089. Segment AnalysisThe global spinal muscular atrophy market is dominated by type I segment which accounts for over 40% of the market share. Key TakeawaysThe global spinal muscular atrophy market is expected to witness high growth over the forecast period. The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 2089. Regional analysisNorth America is currently the dominant region in the global spinal muscular atrophy market share owing to increasing research activities for developing novel therapies.

The Spinal Muscular Atrophy Market is driven by Increasing Adoption of Gene Therapy

naufan 2024-03-14

The spinal muscular atrophy market overview involves treatments focused on slowing down muscle damage and weakness caused by spinal muscular atrophy (SMA). The genetic therapies for spinal muscular atrophy treat the underlying genetic cause of the disease by targeting mutations in the SMN1 gene. The Global spinal muscular atrophy market is estimated to be valued at US$ 2089. Key Takeaways Key players operating in The Spinal Muscular Atrophy Market are Samsung Electronics, Daktronics, Exceptional 3D, LG Electronics, Panasonic Corporation, Sony Corporation, Leyard Optoelectronic Co. The current geopolitical situation is impacting the growth of the Spinal Muscular Atrophy market.

Shining Light on Spinal Muscular Atrophy: Illuminating the Path to Progress

Anjali Pawar 2023-06-06

Shining Light on Spinal Muscular Atrophy: Illuminating the Path to Progress" is a beacon of hope in the realm of SMA. With a focus on scientific discoveries and medical advancements, this content illuminates the path to progress in the fight against Spinal Muscular Atrophy. "Shining Light on Spinal Muscular Atrophy" instills hope and fuels determination in the pursuit of a brighter future for the SMA community. Through a compassionate and informative approach, "Spinal Muscular Atrophy Untangled" serves as a guide for navigating the complex landscape of SMA. " This comprehensive guide unveils the complexities of Spinal Muscular Atrophy (SMA) while providing a clear path towards greater understanding and support.

Global Spinal Muscular Atrophy Treatment Market Growth Rate and Trend Analysis Report 2021-2028

Sheryl Dias 2022-04-19

The global spinal muscular atrophy treatment market size is expected to expand at a significant CAGR during the forecast period, 2021–2028. Compititive LandscapeKey players competing in the spinal muscular atrophy treatment market are Biogen; Novartis AG; F. About Growth Market Reports:GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. com Follow Us: LinkedIn | Twitter

The Ongoing Research And Development Of Gene Therapy To Fuel Growth Of The Spinal Muscular Atrophy Market

Poonam 2023-12-08

The Spinal Muscular Atrophy Market is estimated to be valued at US$ 1813. The Spinal Muscular Atrophy (SMA) Market is fragmented due to the presence of several international and regional players. The clinical pipeline is also filled with several gene therapy candidates which are under clinical evaluation to cure SMA. Porter’s Analysis Threat of new entrants: The spinal muscular atrophy market requires high investments in R&D for drug development. Key players operating in the spinal muscular atrophy market are Biogen, CYTOKINETICS, F.

Spinal Muscular Atrophy (SMA) Treatment Market 2022 Top key Players and Analysis Report Till 2028

Hanisha Sahu 2022-06-21

The latest Spinal Muscular Atrophy (SMA) Treatment Market Research Report published by Value Market Research gives in-depth analysis to show industry trends in the upcoming years. Furthermore, this report covers regional analysis comprising the segments, market size, trends, growth along with top players with their market share and strategic developmentThe broad spinal muscular atrophy (SMA) treatment market has been sub-grouped into type, treatment and route of administration. Request a FREE Sample Copy of Spinal Muscular Atrophy (SMA) Treatment Market Report with Full TOC At: https://www. The key players in the spinal muscular atrophy (SMA) treatment market includes Avexis, Inc. Browse Full Global Spinal Muscular Atrophy (SMA) Treatment Market Research Report With TOC At: https://www.

WHO TO FOLLOW

MORE FROM AUTHOR

Remittance Market is accounted to be US$ 49.49 billion in 2020

google 2022-06-24

Veterinary Molecular Diagnostics Market is estimated to be US$ 5.36 billion by 2030 with a CAGR of 6.10% during the forecast period

google 2022-06-22

Oligonucleotide Synthesis Market

google 2022-06-20

Fleet Telematics Market is estimated to be US$ 44.68 billion by 2030 with a CAGR of 19.8% during the forecast period

google 2022-06-17

Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.

Press enter to search

Global Spinal Muscular Atrophy Treatment Market Business Scope

Data Bridge Market Research 2022-03-08

1% for the forecast period of 2021-2028 Market Analysis and Insights: Global Spinal Muscular Atrophy Treatment Spinal muscular atrophy (SMA) refers to an autosomal recessive neurodegenerative genetic disorder that is generally characterized by weakening of muscles and atrophy. The increase in the number of people suffering from spinal muscular atrophy (SMA) across the globe acts as one of the major factors driving the growth of spinal muscular atrophy (SMA) treatment market. com/reports/global-spinal-muscular-atrophy-sma-treatment-market Global Spinal Muscular Atrophy Treatment Market Scope and Market Size:On the basis of route of administration, the spinal muscular atrophy (SMA) treatment market is segmented into intrathecal, intraspinal, subcutaneous and others. On the basis of end user, the spinal muscular atrophy (SMA) treatment market is segmented into hospitals, homecare, specialty clinics and others Global Spinal Muscular Atrophy Treatment Market Country Level Analysis:The countries covered in the SMA treatment market report are U. dbmr=global-spinal-muscular-atrophy-sma-treatment-market Competitive Landscape & Spinal Muscular Atrophy Treatment Market Share Analysis:The SMA treatment market competitive landscape provides details by competitor.

SMA Treatment Market to Exhibit a Spectacular CAGR of 28.9%

saurabh jadhav 2020-03-18

The global spinal muscular atrophy (SMA) treatment market size is expected to reach USD 14.49 billion by 2026, exhibiting a CAGR of 28.9% during the forecast period.

The rising prevalence of rare diseases around the world will fuel demand for SMA treatment in the forthcoming years, which in turn will aid the growth of the market.

As per the National Policy for the treatment of rare diseases, globally, around 6000 to 8000 rare diseases are estimated to exist with new rare diseases reported on a regular basis.

Furthermore, 80% of all the rare diseases are genetically originated and therefore impact children inexplicably.

Nonetheless, “the growing initiatives by government authorities for pre-diagnosis will impact the spinal muscular atrophy (SMA) treatment market share positively during the forecast period”, predicts our lead analysts at Fortune Business Insights.Market Driver: R Initiatives by Key Players to Spur Sales Opportunities The surge in research and development activities for the improvement of therapies and treatment options by key players will aid the spinal muscular atrophy (SMA) treatment market growth during the forecast period.

Furthermore, the growing initiatives for pre-diagnosis and positive reimbursement policies will boost the spinal muscular atrophy (SMA) treatment market trends in the foreseeable future.

Spinal Laminoplasty Market Witness High Growth Owing to Increasing Incidences of Spinal Cord Injuries

Ishika cmi 2024-02-13

The global spinal laminoplasty market is estimated to be valued at US$ 5. The average costs of a spinal laminoplasty surgery in the US ranges between US$ 15,000 to 30,000. • Lack of skilled orthopedic surgeons impacts the market growth of spinal laminoplasty negatively. Segment Analysis The global spinal laminoplasty market growth is dominated by the anterior laminectomy segment due to increasing preference for anterior laminectomy spinal decompressive surgery among spinal surgeons and neurosurgeons. Asia Pacific is expected to be the fastest growing market for spinal laminoplasty globally between 2024-2030.

Global Flexible Spinal Implants Market Device Technology Market Scenario and Growth Opportunities 2019 - 2023

Rohit Kamble 2020-03-27

Global Flexible Spinal Implants Market Information: by type (rods, hooks, pedicle screws, plates, cages, other); by applications (thoracic, lumbar, cervical, artificial discs, other) – Forecast to 2023The “Flexible Spinal Implants Market ” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue.The Flexible Spinal Implants Market Free Growth Sample will provide valuable insight with an emphasis on the global market including some of the major players such As, Paradigm Spine LLC, Medtronic plc., Abbott Spine, Inc., Raymedica, K2M Group Holdings, Stryker Corporation, Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, Alphatec Holdings, Inc., NuVasive, Inc., Orthofix International N.V., and othersFor Market Flexible Spinal Implants Market analysis, the report covers upstream raw materials, equipment, downstream client survey, Marketing channels, Market development trend and proposals, which more specifically include valuable information By key applications and consumption, key regions and consumption, key Global distributors , major raw materials suppliers and contact information, major manufacturing equipment suppliers and contact information, major suppliers and contact Information, key consumers and contact information, and supply.Flexible Spinal Implants Market Segment by Regions, regional analysis covers:North America(United States, Canada and Mexico)Europe(Germany, France, UK, Russia and Italy)Asia-Pacific(China, Japan, Korea, India and Southeast Asia)South America(Brazil, Argentina, Colombia etc.

)Middle East and Africa(Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Reasons to Purchase this ReportQualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factorsProvision of market value (USD Billion) data for each segment and sub-segmentIndicates the region and segment that is expected to witness the fastest growth as well as to dominate the marketAnalysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each regionThe competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiledAccess Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/flexible-spinal-implants-market-3755The report also appraises the supervisory scenarios which affect various decisions in the market.

With all the data congregated and scrutinized using SWOT analysis, there is a vibrant picture of the competitive scenario of the Global Flexible Spinal Implants Market.

Openings for the future market growth were uncovered and preoccupied competitive threats also textured.About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.Contact:Market Research Future+1 646 845 9312Email: [email protected]

Global Spinal Muscular Atrophy Treatment Market is anticipated to grow at a CAGR of ~13% by 2026

Tejashri 2022-12-09

The Global Spinal Muscular Atrophy Treatment Market is expected to grow at a rate of ~13% by 2026. Some of the main factors propelling the global spinal muscular atrophy treatment market is the rising prevalence of spinal muscular atrophy (SMA), growing awareness of SMA diagnosis and treatment, increasing number of initiatives to improve treatment options for rare diseases, and rising R&D activities to develop novel therapies & treatments for spinal muscular atrophy (SMA). However, the high cost associated with the treatment of spinal muscular atrophy (SMA) is likely to hamper the market growth. Increasing R&D Activities for the Treatment of Spinal Muscular Atrophy Drives the MarketCurrently, there is no known cure for Spinal Muscular Atrophy (SMA). com/spinal-muscular-atrophy-sma-treatment-market/North America Holds the Largest Market Share in Spinal Muscular Atrophy Treatment MarketNorth America holds the major market share of the spinal muscular atrophy treatment market followed by Europe and the Asia Pacific.

Global Spinal Muscular Atrophy (SMA) Treatment Market Size 2021 Emerging Trends, Industry Share, Future Demands, Regional Overview and Forecast To 2027

Jennifer Stevens 2021-05-24

Spinal Muscular Atrophy (SMA) Treatment Market report added by Value Market Research, offering growth, trends, and forecast for each segment along with regional and country analysis.

Further, this report also highlights the regional and country-level market analysis.The report also covers detailed competitive landscape including company profiles of key players operating in the global market.

An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.Get more information on "Global Spinal Muscular Atrophy (SMA) Treatment Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/spinal-muscular-atrophy-sma-treatment-market/download-sampleMarket DynamicsThe increasing awareness by various NGO’s and the public regarding Spinal Muscular Atrophy (SMA) and a growing number of initiatives to improve treatment for rare diseases are fueling the market growth of SMA treatment.

Moreover, improving the healthcare sector is again boosting the market growth.

Whereas, innovation of more efficient drugs and therapies is expected to offer opportunities to SMA treatment market in the forecast period.This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis.

These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities.

Global Spinal Devices Market Industry Insight, Revenue Analysis And Forecast 2029

krajput 2022-10-11

The Global Spinal Devices Market Industry report provides a basic overview of the market including definitions, classifications, applications and industry chain structure. The Global Spinal Devices Market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. com/request-sample/101565Global Spinal Devices Market Overview:The "Global Spinal Devices Market Analysis" is a thorough examination of the Spinal Devices market, with an emphasis on global market trends and analysis. The Spinal Devices market is predicted to grow significantly over the forecast period. com/inquiry-before-buying/101565Key Questions Answered in the Spinal Devices Market Report are:How big is the market for Spinal Devices?

Muscular Dystrophy Treatment Market Opportunities: A Strategic Outlook

Roger 2023-12-29

The Muscular Dystrophy Treatment Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Additionally, increasing research activities for developing new treatment options is another major factor driving the muscular dystrophy treatment market. Increased government initiatives for muscular dystrophy treatmentMany governments across the globe have launched funding programs and initiatives aimed at funding research for developing new treatments for muscular dystrophy. The increased governmental focus on treatment development is expected to significantly drive growth in the muscular dystrophy treatment market in the coming years. Increasing adoption of new treatment paradigmsAdvancements in understanding disease mechanisms of different muscular dystrophies have opened up new treatment paradigms that target specific molecular pathways driving the pathology.

Spinal Muscular Atrophy (SMA) Treatment Market 2022 Top key Players and Analysis Report

Deniyal Berich 2023-06-23

Fastest growing segment fueling the growth of Spinal Muscular Atrophy Market

Sneha 2023-11-29

Major companies such as Biogen and Novartis are focusing on developing advanced gene therapies for SMA through adeno-associated virus vectors. Segment Analysis:The spinal muscular atrophy market is segmented based on type, treatment, route of administration, and distribution channel. By type, the 5q SMA segment dominated the market in 2022 and is expected to continue its dominance over the forecast period. Regional AnalysisNorth America dominated the global spinal muscular atrophy market in 2022 and is expected to continue its dominance over the forecast period. With the market expected to grow at a higher rate, these players are likely to invest more in R&D for innovative treatment options.

What is Spinal Muscular Atrophy (SMA)?

steve mike 2022-04-02

What is Spinal Muscular Atrophy (SMA)? This happens because the specific nerve cells in the body that control muscle movement, called motor neurons, deteriorate and stop working. Without the SMN protein, the motor neurons in the spinal cord stop working and the muscles weaken. In SMA, not enough SMN protein is made and motor neurons stop working, causing muscles to become weaker. People with one healthy and one defective SMN1 gene are known as carriers, and they usually show no symptoms of SMA.

Global Spinal Muscular Atrophy Market Is Estimated To Witness High Growth Owing To Advancements in Treatment Approaches and Increasing Awareness

Cmitejashree 2023-08-29

The global Spinal Muscular Atrophy Market is estimated to be valued at US$ 1,600. The second driver is the increasing awareness about Spinal Muscular Atrophy Market Growth among healthcare professionals and patients. Key Takeaways: The global Spinal Muscular Atrophy Market is expected to witness high growth, exhibiting a CAGR of 13. Key players operating in the global Spinal Muscular Atrophy Market include Biogen, CYTOKINETICS, F. In conclusion, the global Spinal Muscular Atrophy Market is witnessing significant growth due to advancements in treatment approaches and increasing awareness.

Global Spinal Muscular Atrophy (SMA) Treatment Market: Detailed Analysis by Latest Trends, Demand and Forecast to 2026

Trisha Kumari 2020-01-08

Recently published a report entitled Spinal Muscular Atrophy (SMA) Treatment Market projected till 2026, added by Value Market Research, covers key players along with their market share and strategic development adopted by them.

Further, the report provides market size, share, trends, outlook and forecast based on historical data coupled with drivers, restraints, and opportunities.The broad spinal muscular atrophy (SMA) treatment market has been sub-grouped into type, treatment and route of administration.

The report studies these subsets with respect to the geographical segmentation.

The strategists can gain a detailed insight and devise appropriate strategies to target specific market.

This detail will lead to a focused approach leading to identification of better opportunities.Request a FREE Sample Copy of Spinal Muscular Atrophy (SMA) Treatment Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/spinal-muscular-atrophy-sma-treatment-market/download-sampleBy TypeType 1Type 2Type 3Type 4By TreatmentGene TherapyDrugBy Route Of AdministrationOralIntrathecalThe report also covers detailed competitive landscape including company profiles of key players operating in the global market.

The key players in the spinal muscular atrophy (SMA) treatment market includes Avexis, Inc., Biogen, Cytokinetics, Inc., F. Hoffmann - La Roche Ltd, Ionis Pharmaceuticals, Inc., and Novartis AG.

Global Spinal Fusion Market to Reach USD 9.93 Billion by 2027

Prateek Baranwal 2022-03-04

According to Renub Research, report titled “Spinal Fusion Market, Size, Share, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis” the Global Spinal Fusion Device Market was USD 7. Worldwide Spinal Fusion Device Market is anticipated to grow at a CAGR of 4. 8% from 2021-2027The global spinal fusion devices market is predicted to increase moderately, opening up a slew of new prospects. As a result, according to our analysis, the degenerative disc section of the spinal fusion market is expected to multiply. phpCOVID-19's Impact on the Global Spinal Fusion Device Market:The COVID-19 epidemic has had an impact on just about every business.